Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL003713

Drug Information
NameRG3638
SynonymsOnartuzumab
CompanyRoche
Indication1st line non-squamous non-small cell lung cancer
[ICD9: 162   ICD10: C33, C34]
Phase II    
1st line squamous non-small cell lung cancer
[ICD9: 162   ICD10: C33, C34]
Phase II    
Avastin-nave recurrent glioblastoma
[ICD9: 191   ICD10: C71]
Phase II    
Metastatic HER2-negative gastric cancer
[ICD9: 140-229, 151   ICD10: C00-C96, C16]
Phase III    
Metastatic colorectal cancer
[ICD9: 153, 154   ICD10: C18-C21]
Phase II    
Metastatic non-small cell lung cancer
[ICD9: 162   ICD10: C33, C34]
Phase III    
Triple negative metastatic breast cancer
[ICD9: 140-229, 174, 175   ICD10: C00-C96, C50]
Phase II    
TargetMet



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543